marketsgonewild

“President Trump Keeps Promise: Silk Road Creator Ross Ulbricht Receives Full Pardon”

Fulfilling a Controversial Promise: President Trump Pardons Silk Road Creator Ross Ulbricht Recently, President Trump made headlines once again by issuing a full pardon to Ross Ulbricht, the mastermind behind Silk Road, a notorious dark net marketplace. The decision to pardon Ulbricht was met with mixed reactions, with supporters cheering the move while critics raised…

Read More

“Oops, I Did It Again: My Hilarious (and Totally Relatable) Experience with Buying My Own Shares”

Endeavour Announces Transaction in Own Shares The Inside Scoop Hey there, fellow investors and finance enthusiasts! Today, let’s dive into the latest news from Endeavour Mining plc. They just made a big move by purchasing 7,000 of their ordinary shares from Stifel Nicolaus Europe Limited. Talk about taking matters into your own hands! The Nitty…

Read More

“TotalEnergies Faces Setbacks in $20 Billion Mozambique LNG Project, According to FT Reports (2025-01-22)”

France’s TotalEnergies Delays $20 Billion LNG Project in Mozambique Security Concerns Cause Delay France’s TotalEnergies has further postponed its $20 billion liquefied natural gas (LNG) project in Mozambique, citing ongoing security concerns, the Financial Times reported on Wednesday. The project, which was initially scheduled to begin production in 2024, has faced several setbacks due to…

Read More

Sarclisa Approved in the EU as First Anti-CD38 Therapy in Combination with Standard of Care VRd to Treat Transplant-Ineligible Newly Diagnosed Multiple Myeloma

Sarclisa Approved in the EU: A Milestone in Multiple Myeloma Treatment Introduction Recently, Sarclisa received approval in the European Union as the first anti-CD38 therapy to be used in combination with standard-of-care VRd for the treatment of transplant-ineligible newly diagnosed multiple myeloma patients. This marks a significant milestone in the field of oncology and provides…

Read More